Dergiler / GORM:Gynecology Obstetrics & Reproductive Medicine / 2021 / Cilt: 27 - Sayı: 1

Comparison of Survival Outcomes of Lymphovascular Space InvasionNegative and Lymphovascular Space Invasion - Positive Women with Stage IIIC Endometrioid Endometrial Cancer: A Case - Control Study

Sayfa
70–76
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CONCLUSION: Lymphovascular space invasion status seems to be of borderline significance for OS in stage IIIC endometrioid endometrial cancer and impacts recurrence patterns as retroperitoneal recurrences are strongly related to positive lymphovascular space invasion status.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVE: The purpose of this case-control study was to investigate the effect of lymphovascular space invasion on recurrence patterns and survival in patients with stage IIIC endometrioid type endometrial cancer.
📊
Temel Bulgular & Veri:RESULTS: Forty-one patients in the case group and 82 patients in the control group were eligible for the study.
💡
Sonuç & Katkı:CONCLUSION: Lymphovascular space invasion status seems to be of borderline significance for OS in stage IIIC endometrioid endometrial cancer and impacts recurrence patterns as retroperitoneal recurrences are strongly related to positive lymphovascular space invasion status.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

OBJECTIVE: The purpose of this case-control study was to investigate the effect of lymphovascular space invasion on recurrence patterns and survival in patients with stage IIIC endometrioid type endometrial cancer. STUDY DESIGN: A multicenter, retrospective, department database review was performed to identify lymphovascular space invasion-negative and lymphovascular space invasion-positive stage IIIC endometrioid endometrial cancer at five gynecological oncology centers in Turkey. Demographic, clinicopathological and survival data were collected. Cases and controls were matched in terms of age at diagnosis, grade of tumor, depth of myometrial invasion, sub-stage and adjuvant treatment. RESULTS: Forty-one patients in the case group and 82 patients in the control group were eligible for the study. The 5-year OS rates were 94.4% in the lymphovascular space invasion-negative group and 77.2% in the LVSI-positive group (p=0.058). Advanced age (≥58 years) (HR 3.73; 95% CI: 1.19-11.69, p=0.02), grade 3 tumor (HR 2.57; 95% CI: 1.002-6.62, p=0.048) and cervical involvement (HR 2.62; 95% CI: 1.03-6.67, p= 0.04) appeared to be as independent predictors of decreased overall survival (OS). There was a trend towards statistical significance between the presence of lymphovascular space invasion and OS in regression analysis (HR 3.10; 95% CI 0.90-10.67, p=0.05). Recurrence rates were 17.0% (7/41) and 24.4% (20/82) in lymphovascular space invasion-negative and lymphovascular space invasion-positive groups, respectively (p=0.48). There were 5 cases of retroperitoneal recurrences in the lymphovascular space invasion-positive group and no retroperitoneal recurrence among lymphovascular space invasion-negative women. CONCLUSION: Lymphovascular space invasion status seems to be of borderline significance for OS in stage IIIC endometrioid endometrial cancer and impacts recurrence patterns as retroperitoneal recurrences are strongly related to positive lymphovascular space invasion status.

🔖

Bu Makaleye Atıf Yap

CÜYLAN, Z. F., MEYDANLI, M. M., ÖZ, M., TURAN, A., AKBAYIR, Ö., Murat, M., AYHAN, A. (2021). Comparison of Survival Outcomes of Lymphovascular Space InvasionNegative and Lymphovascular Space Invasion - Positive Women with Stage IIIC Endometrioid Endometrial Cancer: A Case - Control Study. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 27 - Sayı: 1, 70–76. https://ajindex.com/articles/226951

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Creasman WT. Morrow CP. Bundy BN. Homesley HD. Graham JE. Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60(8 Suppl):2035-41. doi: 10.1002/1097-0142(19901015)60:8+ 3.0.co;2-8
  2. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103-4. doi: 10.1016/j.ijgo.2009.02.012
  3. Hahn HS. Lee IH. Kim TJ. Lee KH. Shim JU. Kim JW. et al. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer. Aust N Z J Obstet Gynaecol. 2013;53(3):293-7. doi: 10.1111/ajo.12089
  4. Watari H. Todo Y. Takeda M. Ebina Y. Yamamoto R. Sakuragi N. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Gynecol Oncol. 2005;96(3):651-7. doi: 10.1016/j.ygyno.2004. 11.026
  5. Cheewakriangkrai C. Panggid K. Siriaungkul S. Khunamornpong S. Suprasert P. Srisomboon J. Lymphovascular space invasion as a prognostic determinant in uterine cancer. Asian Pac J Cancer Prev. 2007;8(3):363-6
  6. Turan T. Ureyen I. Duzguner I. Ozkaya E. Tasci T. Karalok A. et al. Analysis of patients with stage IIIC endometrial cancer. Int J Gynecol Cancer. 2014;24(6):1033- 41. doi: 10.1097/IGC.0000000000000154
  7. Toptas T. Simsek T. Stage IIIC endometrial cancer: the need for novel subgrouping according to the ratio of metastatic lymph nodes. Arch Gynecol Obstet. 2015;291 (2):391-8. doi: 10.1007/s00404-014-3409-z
  8. Polterauer S. Khalil S. Zivanovic O. Abu-Rustum NR. Hofstetter G. Concin N. et al. Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer. Obstet Gynecol. 2012;119(6):1210-8. doi: 10.1097/AOG. 0b0 13e318255060c. 9. dos Reis R. Burzawa JK. Tsunoda AT. Hosaka M. Frumovitz M. Westin SN. et al. Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer. Int J Gynecol Cancer. 2015;25(7): 1292-9. doi: 10.1097/IGC.0000000000000490
  9. Briët JM. Hollema H. Reesink N. Aalders JG, Mourits MJ. ten Hoor KA. et al. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol. 2005;96(3):799-804. doi: 10. 1016/j.ygyno.2004.11.033
  10. Gemer O. Arie AB. Levy T. Gdalevich M. Lorian M. Barak F. et al. Lymphvascular space involvement compromises the survival of patients with stage I endometrial can